Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 9,305 shares of the financial services provider's stock, valued at approximately $1,551,000.
A number of other hedge funds have also made changes to their positions in the business. Solstein Capital LLC acquired a new stake in Marsh & McLennan Companies in the 4th quarter valued at $25,000. Asset Dedication LLC acquired a new position in shares of Marsh & McLennan Companies during the first quarter worth about $25,000. SHP Wealth Management purchased a new stake in shares of Marsh & McLennan Companies in the fourth quarter worth about $26,000. KERR FINANCIAL PLANNING Corp acquired a new stake in shares of Marsh & McLennan Companies in the fourth quarter valued at about $27,000. Finally, Golden State Wealth Management LLC purchased a new stake in shares of Marsh & McLennan Companies during the 4th quarter valued at about $27,000. Hedge funds and other institutional investors own 87.99% of the company's stock.
Insider Transactions at Marsh & McLennan Companies
In other Marsh & McLennan Companies news, Director Lloyd M. Yates sold 12,000 shares of the stock in a transaction that occurred on Thursday, July 23rd. The stock was sold at an average price of $175.65, for a total transaction of $2,107,800.00. Following the transaction, the director owned 12,001 shares of the company's stock, valued at $2,107,975.65. This trade represents a 50.00% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Martin South sold 7,100 shares of the business's stock in a transaction that occurred on Tuesday, July 28th. The shares were sold at an average price of $189.99, for a total value of $1,348,929.00. Following the completion of the sale, the insider owned 16,632 shares of the company's stock, valued at $3,159,913.68. This trade represents a 29.92% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 36,469 shares of company stock worth $6,291,345. 0.38% of the stock is currently owned by corporate insiders.
Marsh & McLennan Companies Price Performance
MRSH opened at $192.90 on Friday. Marsh & McLennan Companies, Inc. has a 12-month low of $156.60 and a 12-month high of $207.82. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 1.22. The firm has a market capitalization of $92.05 billion, a PE ratio of 23.58, a PEG ratio of 2.67 and a beta of 0.59. The company has a fifty day moving average of $182.75.
Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last released its earnings results on Tuesday, July 21st. The financial services provider reported $2.96 earnings per share for the quarter, topping the consensus estimate of $2.89 by $0.07. The company had revenue of $7.28 billion during the quarter. Marsh & McLennan Companies had a net margin of 14.24% and a return on equity of 32.67%. Marsh & McLennan Companies's quarterly revenue was up 6.2% on a year-over-year basis. On average, equities research analysts forecast that Marsh & McLennan Companies, Inc. will post 10.44 earnings per share for the current fiscal year.
Marsh & McLennan Companies Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Thursday, July 23rd were paid a dividend of $0.99 per share. The ex-dividend date was Thursday, July 23rd. This is an increase from Marsh & McLennan Companies's previous quarterly dividend of $0.90. This represents a $3.96 annualized dividend and a yield of 2.1%. Marsh & McLennan Companies's payout ratio is currently 48.41%.
Analyst Ratings Changes
A number of research firms have weighed in on MRSH. Morgan Stanley upped their price target on Marsh & McLennan Companies from $180.00 to $200.00 and gave the stock an "equal weight" rating in a report on Wednesday, August 19th. Cantor Fitzgerald boosted their target price on shares of Marsh & McLennan Companies from $210.00 to $218.00 and gave the stock an "overweight" rating in a research report on Thursday, July 9th. Wells Fargo & Company upped their target price on shares of Marsh & McLennan Companies from $186.00 to $188.00 and gave the company an "equal weight" rating in a research note on Wednesday, July 22nd. Weiss Ratings raised shares of Marsh & McLennan Companies from a "hold (c-)" rating to a "hold (c)" rating in a research note on Friday, August 7th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Marsh & McLennan Companies from $206.00 to $212.00 and gave the stock an "overweight" rating in a report on Monday, July 13th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, eleven have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $203.50.
Read Our Latest Stock Report on Marsh & McLennan Companies
About Marsh & McLennan Companies
(
Free Report)
Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
